Efficacy and safety of subsequent molecular targeted therapy after immuno-checkpoint therapy, retrospective study of Japanese patients with metastatic renal cell carcinoma (AFTER I-O study).
Autor: | Tomita, Yoshihiko, Kimura, Go, Fukasawa, Satoshi, Numakura, Kazuyuki, Sugiyama, Yutaka, Yamana, Kazutoshi, Naito, Sei, Kabu, Koki, Tajima, Yohei, Oya, Mototsugu |
---|---|
Zdroj: | Japanese Journal of Clinical Oncology; Jun2021, Vol. 51 Issue 6, p966-975, 10p |
Databáze: | Complementary Index |
Externí odkaz: |